Ovarian Cysts Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cysts, including details on causes, treatment, symptoms, infertility.

Volume 6 (2009), Issue 7 (July)

1. Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese.
   Endocrine, 36(1): 16-9. [Abstract] [Full-text]
2. The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.
   J Clin Endocrinol Metab, 94(7): 2665-9. [Abstract] [Full-text]
3. Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.
   J Clin Endocrinol Metab, 94(7): 2579-86. [Abstract] [Full-text]
4. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
   J Clin Endocrinol Metab, 94(7): 2617-25. [Abstract] [Full-text]
5. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
   Cochrane Database Syst Rev. [Abstract] [Full-text]
6. PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women.
   Mol Hum Reprod, 15(8): 459-69. [Abstract] [Full-text]
7. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
   Cardiovasc Res, 83(3): 566-74. [Abstract] [Full-text]
8. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
   Hum Reprod, 24(8): 1982-8. [Abstract] [Full-text]
9. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
   Hum Reprod, 24(8): 2014-22. [Abstract] [Full-text]
10. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.
    Hum Reprod, 24(8): 2007-13. [Abstract] [Full-text]
11. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.
    Hum Reprod, 24(8): 1976-81. [Abstract] [Full-text]
12. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
    Ann Pharmacother, 43(7): 1338-46. [Abstract] [Full-text]
13. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.
    Eur J Endocrinol, 161(2): 317-22. [Abstract] [Full-text]
14. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome.
    Am J Physiol Regul Integr Comp Physiol, 297(2): R387-95. [Abstract] [Full-text]
15. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    BJOG, 116(9): 1242-50. [Abstract] [Full-text]
16. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.
    BMC Med Genet, 10: 64. [Abstract] [Full-text]
17. A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization.
    Nat Rev Endocrinol, 5(8): 462-5. [Abstract] [Full-text]
18. The influence of peritoneal endometriotic lesions on the generation of endometriosis-related pain and pain reduction after surgical excision.
    Arch Gynecol Obstet, 280(3): 369-73. [Abstract] [Full-text]
19. Recruitment strategies for an acupuncture randomized clinical trial of reproductive age women.
    Complement Ther Med, 17(4): 229-35. [Abstract] [Full-text]
20. Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism.
    Diabetes Care, 32(8): 1525-30. [Abstract] [Full-text]

© 2004-2010 Ovarian Cysts Research Today. All Rights Reserved.